Genetic basis of bilateral renal cancer: implications for evaluation and management
- PMID: 19597019
- PMCID: PMC5036849
- DOI: 10.1200/JCO.2009.23.0045
Genetic basis of bilateral renal cancer: implications for evaluation and management
Conflict of interest statement
The author indicated no potential conflicts of interest
Comment on
-
Risk of bilateral renal cell cancer.J Clin Oncol. 2009 Aug 10;27(23):3737-41. doi: 10.1200/JCO.2008.20.6524. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597028
References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Wiklund F, Tretli S, Choueiri TK, et al. The risk of bilateral renal cell cancer. J Clin Oncol. 2009 In Press. - PubMed
-
- Walther MM, Lubensky IA, Venzon D, et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995;154:2010–2014. - PubMed
-
- Vocke CD, Yang Y, Pavlovich CP, et al. High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dube-Associated Renal Tumors. J Natl Cancer Inst. 2005;97:931–935. - PubMed
-
- Gudbjartsson T, Jonasdottir TJ, Thoroddsen A, et al. A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer. 2002;100:476–479. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical